Latest filing published 09 Feb 2021 for Bolt Biotherapeutics, Inc., €25k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -90.8%Entry US$690.80 · Close at T+365 US$63.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Randall C. Schatzman: trading record in brief
Filings by Randall C. Schatzman span 2 companies, the busiest being Alder Biopharmaceuticals Inc and Bolt Biotherapeutics, Inc. Over a trading history stretching from 26 January 2015 to 9 February 2021, the count stands at 46 filings.
Both buying and selling appear: 1 purchase worth €25k, against 26 sales worth €8.5M. Taken together, the sales exceed the purchases by €8.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 18 option exercises. In 2021 alone, the filings show 1 purchase and no sales.
The latest filing, published on 9 February 2021, reports an open-market purchase of €25k in Bolt Biotherapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Randall C. Schatzman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$20.00100.0% of flowCommon StockSEC:0001209191-21-008739:0Canonical exit: 10 May 2021 (T+90)
- 30,000 shares@ US$1.651.3% of flowCommon StockSEC:0001209191-17-010156:0
- 30,000 shares@ US$25.0319.1% of flowCommon StockSEC:0001209191-17-010156:1
- 404 shares@ US$20.200.2% of flowCommon StockSEC:0001209191-17-006429:0
- 10,000 shares@ US$1.650.4% of flowCommon StockSEC:0001209191-16-149146:0
- 10,000 shares@ US$25.166.1% of flowCommon StockSEC:0001209191-16-149146:1
- 8,181 shares@ US$1.270.3% of flowCommon StockSEC:0001209191-16-145134:0
- 5,481 shares@ US$30.954.1% of flowCommon StockSEC:0001209191-16-145134:1
- 2,700 shares@ US$31.552.1% of flowCommon StockSEC:0001209191-16-145134:2
- 10,000 shares@ US$1.270.3% of flowCommon StockSEC:0001209191-16-140250:0
- 10,000 shares@ US$32.487.9% of flowCommon StockSEC:0001209191-16-140250:1
- 10,000 shares@ US$1.270.3% of flowCommon StockSEC:0001209191-16-135311:0
- 5,168 shares@ US$30.653.8% of flowCommon StockSEC:0001209191-16-135311:1
- 4,816 shares@ US$31.683.7% of flowCommom StockSEC:0001209191-16-135311:2
- 16 shares@ US$32.690.0% of flowCommon StockSEC:0001209191-16-135311:3
- 10,000 shares@ US$1.270.3% of flowCommon StockSEC:0001209191-16-134184:0
- 10,000 shares@ US$28.086.9% of flowCommon StockSEC:0001209191-16-134184:1
- 10,000 shares@ US$1.270.3% of flowCommon StockSEC:0001209191-16-125846:0
- 8,035 shares@ US$29.515.7% of flowCommon StockSEC:0001209191-16-125846:1
- 1,965 shares@ US$30.261.4% of flowCommon StockSEC:0001209191-16-125846:2
- 2,986 shares@ US$1.270.1% of flowCommon StockSEC:0001209191-16-123086:0
- 2,986 shares@ US$28.012.0% of flowCommon StockSEC:0001209191-16-123086:1
- 2,997 shares@ US$1.270.1% of flowCommon StockSEC:0001209191-16-123086:2
- 2,997 shares@ US$28.012.0% of flowCommon StockSEC:0001209191-16-123086:3
- 4,017 shares@ US$1.270.1% of flowCommon StockSEC:0001209191-16-123086:4
25 of 46 declarations